Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kakolyris

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Cancer Care|February 13, 2010
Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitalsT C Constantinidis, E Vagka, P Dallidou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatinS Kakolyris, C Kouroussis, K Kalbakis, et al.
Cancer|May 1, 1999
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaA Makris, T J Powles, S Kakolyris, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancerS Kakolyris, C Kouroussis, J Souglakos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancerN Mylonakis, N Tsavaris, C Bacoyiannis, et al.
Histology and Histopathology|May 16, 2000
Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomasP Kanavaros, K Stefanaki, J Vlachonikolis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2001
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancerS Agelaki, S Kakolyris, P Palamidas, et al.
The Journal of Pathology|October 10, 2001
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancerS B Fox, M Taylor, J Grøndahl-Hansen, et al.
International Journal of Genomics|February 15, 2014
γ -H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung CancerE Chatzimichail, D Matthaios, D Bouros, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 27, 2010
Differences between right- and left-sided colon carcinomasA A K Tentes, O S Korakianitis, S Kakolyris, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Cancer Care|February 13, 2010
Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitalsT C Constantinidis, E Vagka, P Dallidou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatinS Kakolyris, C Kouroussis, K Kalbakis, et al.
Cancer|May 1, 1999
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaA Makris, T J Powles, S Kakolyris, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancerS Kakolyris, C Kouroussis, J Souglakos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancerN Mylonakis, N Tsavaris, C Bacoyiannis, et al.
Histology and Histopathology|May 16, 2000
Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomasP Kanavaros, K Stefanaki, J Vlachonikolis, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2001
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancerS Agelaki, S Kakolyris, P Palamidas, et al.
The Journal of Pathology|October 10, 2001
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancerS B Fox, M Taylor, J Grøndahl-Hansen, et al.
International Journal of Genomics|February 15, 2014
γ -H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung CancerE Chatzimichail, D Matthaios, D Bouros, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 27, 2010
Differences between right- and left-sided colon carcinomasA A K Tentes, O S Korakianitis, S Kakolyris, et al.
Pageof 13